Gastrointestinal hemorrhage before anticoagulant therapy in Kawasaki disease: a case report

Chenmin Hu1, Yanping Yu2

  • 1Department of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.

BMC Pediatrics
|January 29, 2020
PubMed

Insights

Kawasaki disease (KD), a vasculitis causing acquired heart disease in children, can present with rare gastrointestinal bleeding. Early diagnosis is crucial, especially when abdominal symptoms precede characteristic KD signs.

Area of Science:

  • Pediatric Rheumatology
  • Pediatric Cardiology
  • Pediatric Gastroenterology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children, characterized by acute febrile multisystem vasculitis.
  • KD's systemic nature can mimic other conditions, potentially delaying diagnosis, particularly when gastrointestinal symptoms are prominent.
  • While gastrointestinal issues are common in KD, significant gastrointestinal bleeding is a rare but serious manifestation.

Observation:

  • A 4-year-old boy presented with abdominal pain, fever, rash, and gastrointestinal hemorrhage.
  • The patient was diagnosed with complete Kawasaki disease.
  • The child recovered well after standard treatment without complications.

Findings:

  • Kawasaki disease can manifest with severe gastrointestinal bleeding, even in the absence of typical KD symptoms.
  • Abdominal pain and fever in children warrant consideration for Kawasaki disease, especially when accompanied by gastrointestinal bleeding.
  • Prompt diagnosis and management of KD are essential to prevent severe complications like cardiac issues.

Implications:

  • Clinicians should consider Kawasaki disease in children with unexplained fever and abdominal symptoms, including gastrointestinal bleeding.
  • Awareness of rare KD presentations like gastrointestinal hemorrhage is vital for timely diagnosis and treatment.
  • Early recognition and intervention in Kawasaki disease can prevent long-term sequelae, particularly cardiovascular complications.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
315
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
157
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
231